WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke MolecuTech wurde als Bildmarke am 31.07.2013 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Bildmarke |
| Aktenzeichen | 1190397 |
| Registernummer | 4009221800000 |
| Länder | 
|
| Basismarke |
Nr. 4009221800000,
04. Juni 2012
|
| Anmeldedatum | 31. Juli 2013 |
| Ablaufdatum | 31. Juli 2023 |
Markeninhaber
76, Seori-ro, Idong-myeon,
Cheoin-gu, Yongin-si
KR
Cheoin-gu, Yongin-si
KR
76, Seori-ro, Idong-myeon,
Cheoin-gu, Yongin-si
KR
Cheoin-gu, Yongin-si
KR
Markenvertreter
3rd Fl., Sejung Bldg.,
823-9 Yoksam-Dong,
KR
Waren und Dienstleistungen
05
Molecular diagnostic preparations for detecting
mycobacterium tuberculosis (MTB) by real-time PCR
amplification; molecular diagnostic preparations for
simultaneously detecting mycobacterium tuberculosis (MTB)
and nontuberculous mycobacteria (NTM) by real-time PCR
amplification; molecular diagnostic preparations for
identifying mycobacterium tuberculosis (MTB) and a total of
19 kinds of nontuberculous mycobacteria (NTM) and detecting
about 100 kinds of nontuberculous mycobacteria (NTM) by
analyzing PCR amplification products using a reverse blot
hybridization assay (REBA); molecular diagnostic
preparations for simultaneously detecting rifampin and
isoniazid susceptibilities by analyzing PCR amplification
products using a reverse blot hybridization assay (REBA);
molecular diagnostic preparations for detecting resistance
to fluoroquinolone, kanamycin and streptomycin, which are
second-line drugs, by analyzing PCR amplification products
using a reverse blot hybridization assay (REBA); molecular
diagnostic preparations for simultaneously detecting human
papilloma virus (HPV), the major cause of uterine cervical
cancer and a total of 25 kinds of HPV by analyzing PCR
amplification products using a reverse blot hybridization
assay (REBA); molecular diagnostic preparations for
analyzing the rpoB gene region, which shows species-specific
diversity, by PCR-restriction fragment length polymorphism
analysis (PCR-RFLP, PRA); molecular diagnostic preparations
for simultaneously detecting mycobacterium tuberculosis
(MTB) and nontuberculous mycobacteria (NTM) by PCR
amplification of the RD (Region of Difference) gene region,
which present specifically in mycobacterium tuberculosis
(MTB), and the rpoB gene region which is present commonly in
all mycobacteria, including MTB; molecular diagnostic
preparations for detecting mycobacterium and body fluids,
which contain a small number of bacteria
10
A fully automatic system related to tuberculosis diagnosis;
a medical system for real-time gene amplification
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 23. Juni 2022 | 2022/26 Gaz | US | RAW: Total Invalidation |
| 01. Mai 2015 | 2015/19 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 03. Dezember 2014 | 2014/49 Gaz | EM | Ablehnung |
| 10. November 2014 | 2014/46 Gaz | CN | Ablehnung |
| 07. Februar 2014 | 2014/7 Gaz | US | Ablehnung |
| 31. Juli 2013 | 2014/3 Gaz | KR | Eintragung |
ID: 141190397